Conformational Color Polymorphism and Control of Crystallization of 5‐Methyl‐2‐[(4‐methyl‐2‐nitrophenyl)amino]‐3‐thiophenecarbonitrile

5‐Methyl‐2‐[(4‐methyl‐2‐nitrophenyl)amino]‐3‐thiophenecarbonitrile is an example of conformational and color polymorphism. The compound crystallizes in red (R), dark red (DR), light red (LR), and orange (O) modifications. There are two specific goals for this study. One is to characterize the comple...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical sciences Vol. 90; no. 3; pp. 371 - 388
Main Authors He, Xiaorong, Griesser, Ulrich J., Stowell, Joseph G., Borchardt, Thomas B., Byrn, Stephen R.
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 01.03.2001
John Wiley & Sons, Inc
Wiley
American Pharmaceutical Association
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:5‐Methyl‐2‐[(4‐methyl‐2‐nitrophenyl)amino]‐3‐thiophenecarbonitrile is an example of conformational and color polymorphism. The compound crystallizes in red (R), dark red (DR), light red (LR), and orange (O) modifications. There are two specific goals for this study. One is to characterize the complex thermodynamic relationship among these four known forms, and the other is to use the knowledge of the thermodynamic relationship to control the crystallization of these forms. The different forms were characterized by X‐ray powder diffractometry as well as Fourier‐transform infrared (FT‐IR) and Raman spectroscopy; their complex thermodynamic relationships were determined by thermal analysis, solubility measurements, and slurry conversion studies. According to the solubility results, all forms are enantiotropically related: R is the thermodynamically most stable form above 60°C, O is the most stable form between room temperature and 60°C, LR is the most stable form below −15°C, and DR is metas‐table throughout the entire temperature range. DR, LR, and O have very similar free energy at ambient temperature, which is the reason for the complex transition behavior. Finally, a schematic energy–temperature diagram was constructed that combines all experimental data in a comprehensive thermodynamic picture and provides insights into how to control the crystallization of the individual forms. © 2001 Wiley‐Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 90:371–388, 2001
Bibliography:ArticleID:JPS12
istex:2F1B60DDC6F367F31BC1B108FE4F2EF21663F537
ark:/67375/WNG-MS9V82P0-T
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-3549
1520-6017
DOI:10.1002/1520-6017(200103)90:3<371::AID-JPS12>3.0.CO;2-N